Edison Issues Report on Percheron Therapeutics (PER) #EdisonGroup #Flash #Healthcare #PER #PercheronTherapeutics #Banking #ComputerHardware #ComputerSoftware #FinancialServices #Hardware #Software #Investing
London, United Kingdom--(Newsfile Corp. - October 7, 2025) - Edison issues report on Percheron Therapeutics (ASX: PER)Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the compound's favourable safety and tolerability profile (maximum tolerated dose not reached with
http://dlvr.it/TNWm9q
http://dlvr.it/TNWm9q
Comments
Post a Comment